Cell Signaling & Molecular Targets in Cancer (Record no. 100914)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 04054nam a22004575i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 978-1-4614-0730-0 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20140220083240.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 111130s2012 xxu| s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781461407300 |
| -- | 978-1-4614-0730-0 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/978-1-4614-0730-0 |
| Source of number or code | doi |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC261-271 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MJCL |
| Source | bicssc |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED062000 |
| Source | bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 614.5999 |
| Edition number | 23 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Chatterjee, Malay. |
| Relator term | editor. |
| 245 10 - TITLE STATEMENT | |
| Title | Cell Signaling & Molecular Targets in Cancer |
| Medium | [electronic resource] / |
| Statement of responsibility, etc | edited by Malay Chatterjee, Khosrow Kashfi. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1. |
| 264 #1 - | |
| -- | New York, NY : |
| -- | Springer New York, |
| -- | 2012. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | XI, 328 p. 53 illus., 43 illus. in color. |
| Other physical details | online resource. |
| 336 ## - | |
| -- | text |
| -- | txt |
| -- | rdacontent |
| 337 ## - | |
| -- | computer |
| -- | c |
| -- | rdamedia |
| 338 ## - | |
| -- | online resource |
| -- | cr |
| -- | rdacarrier |
| 347 ## - | |
| -- | text file |
| -- | |
| -- | rda |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Acknowledgement -- GRB2 Signaling as a Molecular Target for Cancer -- Human arylamine N-acetyltransferase 1 : from drug metabolism to drug target -- Targeting Argininosuccinate Synthetase in Cancer Therapy -- Parathyroid hormone-related peptide signaling in cancer -- Signaling Molecules as Selective Targets for Therapeutic Strategies in Multiple Myeloma -- Role of Bile Acids in Carcinogenesis of Gastrointestinal Tract -- AIB1: A Transcriptional Coactivator which Integrates Signaling Crosstalk in Cancer Cells -- Rational Design of DNA Anti-cancer Agent that Targets Signal Transducer and Activator of Transcription 3 (Stat3) for Cancer Therapy -- Estrogen Receptor Signaling in Lung Cancer -- Microparticle Dissemination of Biological Activities: Implications for Cancer Biology -- Protein Kinase D Signaling in Cancer -- Cell Signaling and Cancer: Integrated, Fundamental Approach Involving Electron Transfer,Reactive Oxygen Species and Antioxidants -- PPARg, Thiazolidinediones, Lung Cancer -- Targeting Signal Transducer and Activator of Transcription (STAT) for Anti-Cancer Therapy -- Index . |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | The abnormal behavior of all cancer cells regardless of cancer type is irregular cell signaling pathway activity. A mechanistic approach dealing with a fundamental and molecular view based signaling cascade are exciting and dynamic areas of cancer research. This book illuminates what we know, how we know and what remains to be discovered in this regard. The book explore and identify not only the key compounds of cell signaling pathway but also the interaction between them, the cross-talk. This book bring together up-to-date summaries of the signaling components that are likely to be used in diagnosis, prognosis and novel target for pharmaceutical intervention and therapeutic development and highlight the importance of molecular approach to clinical cancer research. A lot clinical trials and outcome are promising. The translation of recent advance in the knowledge of intracellular signaling into the generation of innovative molecular targeted cancer therapy are essential features of this book. Goals are manifold such as, resensitise chemoresistant target, capitalize on different mechanism of action and gain an advantage in the identification of best combination of drugs to induce clinically relevant response. The expert review compile in this book is an invaluable resource for graduate researcher and established scientist working in cell biology, pharmacy, experimental and molecular therapeutics and molecular medicine. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medicine. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Oncology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Toxicology. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Biomedicine. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Cancer Research. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Pharmacology/Toxicology. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kashfi, Khosrow. |
| Relator term | editor. |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY | |
| Title | Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Display text | Printed edition: |
| International Standard Book Number | 9781461407294 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | http://dx.doi.org/10.1007/978-1-4614-0730-0 |
| 912 ## - | |
| -- | ZDB-2-SBL |
No items available.